Fiessinger J N
Service de Médecine Vasculaire, Hôpital Broussais, Paris, France.
Nouv Rev Fr Hematol (1978). 1994 Apr;36(2):179-81.
Arterial and venous thrombotic complications have being increasingly recognized as a major cause of mortality and morbidity in polycythemia vera. The risk can be increased with the treatment. Actually, we can not precisely evaluate the risk of previous venous and arterial lesions, however we have non invasive techniques that permit an accurate evaluation of the vascular bed in patients without recent thrombotic events. The ratio cost-efficacy of the vascular explorations has to be discussed according to the risk factors. In patients with a recent arterial thrombotic event, extensive vascular investigations are mandatory.
动脉和静脉血栓形成并发症日益被认为是真性红细胞增多症患者死亡和发病的主要原因。治疗可能会增加这种风险。实际上,我们无法精确评估既往静脉和动脉病变的风险,然而我们有非侵入性技术,可在近期无血栓形成事件的患者中准确评估血管床。必须根据风险因素讨论血管检查的成本效益比。对于近期发生动脉血栓形成事件的患者,必须进行广泛的血管检查。